A Dose-Escalation Study in Participants With Advanced Cancer

Clinical trial NCT01524224 · COMPLETED

Trial details

NCT number: NCT01524224
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-01-01
Primary completion: 2012-11-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.